Výsledky vyhledávání - "Janet E. Rush"

Efficacy of Glucarpidase (Carboxypeptidase G2) in Patients with Acute Kidney Injury After High-Dose Methotrexate Therapy

Autor: Nalini Jayaprakash, Robbin Christensen, Brigitte C. Widemann, Nikhil Chauhan, Stefan Schwartz, Scott C. Howard, Claire Daugherty, Ching-Hon Pui, Janet E. Rush, Thomas R. King

Publikováno v: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 34:427-439

STUDY OBJECTIVE Because the incidence rate of renal impairment is 2–10% for patients treated with high-dose methotrexate and renal impairment develops in 0–12.4% of patients treated for osteosarcoma, we sought to evaluate the efficacy of glucarpi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5ba3b2505f8e4c20767bf5c9749026b
https://doi.org/10.1002/phar.1360

Zobrazit plný text záznamu

Clinical significance of cerebrovascular gas emboli during polidocanol endovenous ultra-low nitrogen microfoam ablation and correlation with magnetic resonance imaging in patients with right-to-left shunt

Autor: Janet E. Rush, Kathleen Gibson, John D. Regan, Stanley A. Hirsch, Cynthia K. Shortell, David Wright

Publikováno v: Journal of Vascular Surgery. 53:131-137

Background Foam generated by manual agitation of liquid sclerosant with air or gas is routinely utilized to treat refluxing veins. Although generally well tolerated, serious neurological events have been reported. The composition and properties of th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bc6bc10575b8467c83ec2291596f9a2
https://doi.org/10.1016/j.jvs.2010.06.179

Zobrazit plný text záznamu

High prevalence of right-to-left shunt in patients with symptomatic great saphenous incompetence and varicose veins

Autor: Charles McCollum, Alexander Razumovsky, David D. I. Wright, Jean Barclay, Kathleen Gibson, Janet E. Rush

Publikováno v: Journal of vascular surgery. 51(1)

Background Varicose veins are common and increasingly are being treated by less invasive endoscopic methods such as foam sclerotherapy. Patent foramen ovale (PFO) is also common, present in approximately one-quarter of adults. PFO allows bubbles intr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a74bcf8f834cde13239d716647220132
https://pubmed.ncbi.nlm.nih.gov/19837542

Zobrazit plný text záznamu

Clinical trial and compassionate use experience with glucarpidase for methotrexate toxicity

Autor: Claire Daugherty, Scott C. Howard, Nikhil Chauhan, Thomas King, Nalini Jayaprakash, Janet E. Rush, Brigitte C. Widemann

Publikováno v: Journal of Clinical Oncology. 30:6530-6530

6530 Background: High dose methotrexate (MTX) is used to treat acute lymphoblastic leukemia (ALL), osteogenic sarcoma, non-Hodgkin lymphoma (NHL), and other cancers. MTX-associated renal impairment with delayed MTX elimination develops after 2 to 10%

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::afb50e4807269f5d9c8516fa53358495
https://doi.org/10.1200/jco.2012.30.15_suppl.6530

Zobrazit plný text záznamu

Drugs for Heart Failure

Autor: Janet E. Rush, Mariell Jessup

Publikováno v: Early Phase Drug Evaluation in Man ISBN: 9781349107070

Assessing a drug for efficacy and safety in heart failure is a challenging task (Guyatt, 1986). For example, six compounds have been considered by the US Food and Drug Administration (FDA) during the 1980s: captopril, enalapril, amrinone, milrinone,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22345e371169fb881d6ae394375361fa
https://doi.org/10.1007/978-1-349-10705-6_25

Zobrazit plný text záznamu

Tolerance and safety of enalapril

Autor: Janet E. Rush, F. Moncloa, J. F. Walker, M. A. Gabriel, W. McFate Smith, R. O. Davies, D. M. Kramsch

Publikováno v: British Journal of Clinical Pharmacology. 18:249S-255S

Enalapril is the result of a targeted research programme to develop a non-mercapto converting enzyme inhibitor with a long duration of action and an improved safety profile for use in the therapy of hypertension and congestive heart failure. Over 350

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4be7ebad4b896da70d396158e8f63a2f
https://doi.org/10.1111/j.1365-2125.1984.tb02604.x

Zobrazit plný text záznamu

Short- and long-acting angiotensin-converting enzyme inhibitors: A randomized trial of lisinopril versus captopril in the treatment of congestive heart failure

Autor: Richard Katz, J.L. Rouleau, Janet E. Rush, Mary B. Fisher, Paul Wolfson, Stuart Rich, Barry Hackshaw, Philip Kirlin, Jay M. Sullivan, Joseph Pigeon, Eric Powers, Thomas D. Giles, Mark Haugland, Anthony J. Chiaramida

Publikováno v: Journal of the American College of Cardiology. 13(6):1240-1247

A randomized, parallel, double-blind study was performed with lisinopril, a long-acting angiotensin-converting enzyme inhibitor, versus captopril, a shorter-acting angiotensin-converting enzyme inhibitor, in the treatment of congestive heart failure.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e72ffc5c93ff94ee2d80382fc8d0eec5

Zobrazit plný text záznamu

Tolerability of enalapril in congestive heart failure

Autor: Natalie J. Warner, Maureen E. Keegan, Janet E. Rush

Publikováno v: The American Journal of Cardiology. 63:D33-D37

This report reviews the tolerability profile of enalapril, an angiotensin-converting enzyme (ACE) inhibitor, in the treatment of patients with congestive heart failure. Data have been collected from 546 patients treated with enalapril for up to 9 mon

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b508d21210b2480f2386c61746ec68ad
https://doi.org/10.1016/0002-9149(89)90415-3

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání